HMGB1 was identified in our PRKN ubiquitylome screen as a high-confidence substrate of PRKN ubiquitination in cancer (30), and it is known that multiple posttranslational modifications are involved in subcellular trafficking of HMGB1 (48). The gene discussed is PRKN; the disease is cancer.